Literature DB >> 24585567

Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Henry Masur1, John T Brooks, Constance A Benson, King K Holmes, Alice K Pau, Jonathan E Kaplan.   

Abstract

In May 2013, a revised and updated version of the Centers for Disease Control and Prevention/National Institutes of Health/HIV Medicine Association Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was released online. These guidelines, since their inception in 1989, have been widely accessed in the United States and abroad. These guidelines have focused on the management of HIV/AIDS-related opportunistic infections that occur in the United States. In other parts of the world, the spectrum of complications may be different and the resources available for diagnosis and management may not be identical to those in the United States. The sections that have been most extensively updated are those on immune reconstitution inflammatory syndrome, tuberculosis, hepatitis B, hepatitis C, human papillomavirus, and immunizations. The guidelines will not be published in hard copy form. This document will be revised as needed throughout each year as new data become available.

Entities:  

Keywords:  HIV/AIDS; guideline; online; opportunistic infections; revision

Mesh:

Year:  2014        PMID: 24585567      PMCID: PMC3982842          DOI: 10.1093/cid/ciu094

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-08-20

2.  1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.

Authors: 
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

3.  The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.

Authors:  Kelly A Gebo; Rita Kalyani; Richard D Moore; Michael J Polydefkis
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

4.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Authors:  J E Kaplan; H Masur; K K Holmes; M M McNeil; L B Schonberger; T R Navin; D L Hanson; P A Gross; H W Jaffe
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

5.  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Authors:  Stephen D Lawn; Motasim Badri; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

6.  The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.

Authors:  Antonella d'Arminio Monforte; Caroline A Sabin; Andrew Phillips; Jonathan Sterne; Margaret May; Amy Justice; Francois Dabis; Sophie Grabar; Bruno Ledergerber; John Gill; Peter Reiss; Matthias Egger
Journal:  Arch Intern Med       Date:  2005-02-28

7.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

8.  Retention among North American HIV-infected persons in clinical care, 2000-2008.

Authors:  Peter Rebeiro; Keri N Althoff; Kate Buchacz; John Gill; Michael Horberg; Hartmut Krentz; Richard Moore; Timothy R Sterling; John T Brooks; Kelly A Gebo; Robert Hogg; Marina Klein; Jeffrey Martin; Michael Mugavero; Sean Rourke; Michael J Silverberg; Jennifer Thorne; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

9.  Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.

Authors:  H Masur
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

10.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Authors:  Jonathan E Kaplan; Henry Masur; King K Holmes
Journal:  MMWR Recomm Rep       Date:  2002-06-14
View more
  82 in total

Review 1.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

2.  Clinical Characteristics and Prognosis of Penicilliosis Among Human Immunodeficiency Virus-Infected Patients in Eastern China.

Authors:  Jun Chen; Renfang Zhang; Yinzhong Shen; Li Liu; Tangkai Qi; Zhenyan Wang; Wei Song; Yang Tang; Hongzhou Lu
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

3.  Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.

Authors:  Khushbu Shah; Sherry Queener; Vivian Cody; Jim Pace; Aleem Gangjee
Journal:  Bioorg Med Chem Lett       Date:  2019-06-04       Impact factor: 2.823

Review 4.  Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.

Authors:  Muath Helal; Ekaterina Dadachova
Journal:  Cancer Biother Radiopharm       Date:  2018-08-22       Impact factor: 3.099

5.  β-Glucans Are Masked but Contribute to Pulmonary Inflammation During Pneumocystis Pneumonia.

Authors:  Geetha Kutty; A Sally Davis; Gabriela A Ferreyra; Ju Qiu; Da Wei Huang; Monica Sassi; Lisa Bishop; Grace Handley; Brad Sherman; Richard Lempicki; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2016-06-19       Impact factor: 5.226

6.  Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.

Authors:  S F Assimakopoulos; V Stamouli; D Dimitropoulou; A Spiliopoulou; G Panos; E D Anastassiou; M Marangos; I Spiliopoulou
Journal:  Infection       Date:  2015-01-27       Impact factor: 3.553

Review 7.  Pharmacologic and clinical evaluation of posaconazole.

Authors:  Jason N Moore; Jason R Healy; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2015-05       Impact factor: 5.045

8.  Disseminated tuberculous lymphadenitis presenting as cervical mass in patient with HIV infection, worsening after antiretroviral initiation: diagnosis and treatment challenges.

Authors:  Alain Bruno Tagne Nouemssi
Journal:  BMJ Case Rep       Date:  2018-03-15

Review 9.  Human papillomavirus vaccination in HIV-infected women: need for increased coverage.

Authors:  Erna Milunka Kojic; Aadia I Rana; Susan Cu-Uvin
Journal:  Expert Rev Vaccines       Date:  2015-11-24       Impact factor: 5.217

Review 10.  Reducing HIV Risk Behaviors Among Black Women Living With and Without HIV/AIDS in the U.S.: A Systematic Review.

Authors:  Amber I Sophus; Jason W Mitchell
Journal:  AIDS Behav       Date:  2020-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.